Organ-on-chip Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Organ-on-chip 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r epo r t  b y  I M ARC  G r oup ,  t i t l ed  " O rgan - on- c h i p  M arke t :  
G l o ba l  I ndu st ry  T re nds ,  Sh are ,  S i ze ,  G row t h ,  O pp or t u n i t y  an d  Fo recas t  20 24 -
2032 , "  t he  g loba l  o r g an - o n - ch ip  m ar ke t  s i ze  r each ed  U S$  61 . 6  M i l l i on  in  202 3 .
Factors  Af fect ing the  Growth of  the Organ-on-Chip Indust ry :
Report Research and Deve lopment  Act iv i t ies:
The  o r gan - on - c h ip  ( O oC)  m ar k e t  i s  subs t an t i a l l y  d r i v en  by  i t s  t r ans f o r m a t i ve  im p ac t  
on  p ha r m aceu t i ca l  r esea r ch  an d  dev e lopm en t .  Thes e  m ic r o f l u i d i c  dev ic es ,  wh ich  
Highlight and m im ic  t h e  p hys io log i ca l  r es pons es  o f  o r gan  t i s sues ,  p r ov ide  a  m o r e  a ccu r a t e  a nd  
p r ed i c t i ve  m od e l  f o r  d r ug  e f f i ca cy  and  s a f e t y  t es t i ng  com par e d  t o  t r ad i t i o na l  ce l l  
cu l t u r es  a nd  a n im a l  m od e ls .  
Description The  ab i l i t y  o f  O oC s  t o  s im u la t e  hum a n  o r g an  dy nam ic s  unde r  va r i ous  co nd i t io ns  
enab les  pha r m ac eu t i c a l  c om p an ies  t o  be t t e r  p r ed i c t  how  d r ugs  w i l l  be have  i n  hum an  
bod ie s ,  po t en t i a l l y  r e duc in g  t he  in c iden ce  o f  l a t e - s t age  d r ug  t r i a l  f a i lu r es .  T h i s  
acce le r a t es  t h e  d r u g  deve lopm en t  p r oces s  and  s ign i f i can t l y  cu t s  cos t s  by  m in im iz ing  
t he  r e l i ance  o n  cos t l y  an im a l  t es t in g  and  h um an  t r i a l s .  A s  r egu la t o r y  bo d ies  
i nc r ease  t he i r  e m phas i s  on  d r ug  sa f e t y  and  e f f i c acy ,  t he  dem and  f o r  a dvan ced  
t es t i ng  m ode l s  l i ke  O oC s  i s  e xpec t ed  t o  r i s e ,  f u r t he r  p r o pe l l i ng  t he  m a r ke t  g r ow t h .
Demand for  Personal ized Medic ine:
The  organ-on-ch ip  marke t  i s  a lso  f ue led  by  t he  g row ing  demand  f o r  pe rsona l i zed  
med ic ine .  OoCs  o f fe r  a  un ique  p la t f o rm f o r  deve lop ing  ind iv idua l i zed  the rapy  
p lans  by  a l low ing  the  s t udy  o f  spec i f i c  pa t i en t -de r i ved  ce l l s  w i th in  a  con t ro l led  
Report mic roenv i ronmen t .  Th i s  capab i l i t y  i s  c ruc ia l  f o r  unders t and ing  pa t ien t -spec i f i c  responses  to  d i f f e ren t  t rea tment s ,  t he reby  fac i l i t a t ing  t he  cus t omiza t ion  o f  
t herap ies  to  ach ieve  op t imum c l in i ca l  ou tcomes .  
Highlight and As hea l thca re  con t inues  t o  sh i f t  t owards  pe rsona l i zed  t rea t ment  app roaches ,  t he  
adopt ion  o f  o rgan-on -ch ip  techno log ies  i s  expec t ed  to  inc rease.  The po t en t ia l  o f  
Description OoCs  to  s i gn i f i can t l y  reduce t he  t ime and  cos t  assoc ia t ed  w i th  pe rsona l i zed  d rug  tes t ing  and  deve lopmen t  makes  them h igh ly  va luab le  i n  c l i n i ca l  se t t i ngs ,  d r i v ing  
fu r the r  inves t men t  and  research  i n  t h i s  p romis ing  f ie ld .
Technologica l  Advancements:
Advancement s  i n  m ic ro fabr i ca t ion  and  t i s sue  eng ineer ing  a re  key  f ac to rs  d r i v ing  
the  g rowth  o f  t he  o rgan-on -ch ip  marke t .  The  i n teg ra t ion  o f  cu t t i ng -edge 
techno log ies  such  as  3D b iopr in t ing ,  m ic ro f lu id i cs ,  and  advanced b iomate r i a l s  
has  enhanced  t he  func t iona l i t y  and  re l iab i l i t y  o f  OoC sys tems.
These  innova t ions  have  a l l owed  fo r  the  deve lopment  o f  more  comp lex  and  
soph is t i ca ted  o rgan  mode ls  tha t  can  p rov ide  p rec ise  ins igh ts  in to  o rgan  
behav io rs ,  d isease  mechan isms,  and  the rapeu t i c  responses.  Add i t iona l l y ,  t he  
ab i l i t y  t o  in teg ra te  sensors  d i rec t ly  in to  OoC dev ices  fo r  rea l - t ime  mon i to r ing  
o f  b io log ica l  p rocesses  o f fe rs  unp receden ted  oppor tun i t i es  fo r  research  and  
deve lopment .  Th is  techno log ica l  in teg ra t ion  improves  the  p red ic t i ve  accuracy  
Report o f  OoC mode ls  and  expands  the i r  app l i ca t ions  ac ross  va r ious  b iomed ica l  and  
sc ien t i f i c  d isc ip l i nes ,  t he reby b roaden ing  the  marke t  reach .
Highlight and 
Request  for  a  PDF sample  o f  th is  repor t :  
Description h t tps : / /www. imarcgroup .com/organ-on-ch ip -marke t / reques tsamp le
Report Description
Global  Organ-on-chip Market  Trends:
Present ly ,  w i th  advancements  in  p rec is ion  med ic ine ,  there 's  a  growing  need fo r  ta i lo red  t rea tment  op t ions.  
OOC technology enab les  the model ing  o f  ind iv idua l  pa t ien t  responses to  drugs ,  fac i l i ta t ing  the  deve lopment  o f  
persona l ized  therap ies .  Bes ides ,  concerns  over  an ima l  we l fa re  and  the  l im i ta t ions o f  t rad i t iona l  an ima l  mode ls  
have  prompted a  sh i f t  towards  a l te rnat ive  tes t ing methods.  
OOC p la t fo rms o f fe r  a  more e th ica l  and  phys io log ica l l y  re levan t  approach fo r  d rug screen ing and  tox ic i ty  
tes t ing .  Moreover ,  the in tegra t ion  o f  A I  and machine  learn ing  a lgor i thms wi th  OOC sys tems enhances data  
ana lys is  and pred ic t ion  capabi l i t i es .  Th is  a l lows for  more accurate  mode l ing o f  human phys io logy  and  d rug  
responses,  acce le ra t ing d rug  d iscovery  and  deve lopment  p rocesses.
Looking forward,  the market  to  reach US$ 541 .8  Mi l l ion  by 2032,  exhib i t ing  a  growth rate  (CAGR)  of  
26 .5% during  2024-2032.
View Report  TOC,  F igures and Tables :  h t tps: / /www. imarcgroup.com/organ-on-chip-market
Breakup by Off ering:
• Products
• Services
Breakup by Type:
• Liver
Report • Heart
•
Segmentation Lung
• Kidney
• Others
Breakup by Application:
• Physiological  Model Development
• Drug Discovery
• Toxicology Research
Breakup by End Use:
• Pharmaceutical  and Biotechnology Companies
• Academic and Research Insti tutes
• Cosmetics Industry
• Others
Report 
Breakup by Region:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Allevi Inc.
• Altis Biosystems
• AxoSim
• BiomimX S.r. l .
Competitive 
• Elvefl ow
Landscape • Emulate Inc.
with Key • InSphero
• MIMETAS
Players
• Nortis Inc.
• TARA Biosystems Inc.
• TissUse GmbH
What was the size of the global organ-on-chip market in 
2023?
What is the expected growth rate of the global organ-
on-chip market during 2024-2032?
What are the key factors driving the global organ-on-
chip market?
Key 
What has been the impact of COVID-19 on the global 
organ-on-chip market?
Questions 
What is the breakup of the global organ-on-chip market 
Answered in based on the type?
the Report What is the breakup of the global organ-on-chip market based on the application?
What is the breakup of the global organ-on-chip market 
based on the end use?
What are the key regions in the global organ-on-chip 
market?
Who are the key players/companies in the global organ-
on-chip market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  O r g a n - o n - c h i p  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  O f f e r i n g
    6 . 1     P r o d u c t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     S e r v i c e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  T y p e
    7 . 1     L i v e r
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
       
    7 . 2     H e a r t
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     L u n g
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     K i d n e y
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t
    7 . 5     O t h e r s
        7 . 5 . 1  M a r k e t  T r e n d s
Table of         7 . 5 . 2  M a r k e t  F o r e c a s t8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    8 . 1     P h y s i o l o g i c a l  M o d e l  D e v e l o p m e n t
        8 . 1 . 1  M a r k e t  T r e n d s
Contents         8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     D r u g  D i s c o v e r y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     T o x i c o l o g y  R e s e a r c h
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  E n d  U s e
    9 . 1     P h a r m a c e u t i c a l  a n d  B i o t e c h n o l o g y  C o m p a n i e s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
    9 . 2     A c a d e m i c  a n d  R e s e a r c h  I n s t i t u t e s
        9 . 2 . 1  M a r k e t  T r e n d s
        9 . 2 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /o rga n - o n - c h i p -ma rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: